HemoGenyx

London, United Kingdom

New treatment for blood diseases, such as leukemia and lymphoma.

$4.1M raised

Apr 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has HemoGenyx raised?

HemoGenyx has raised $4.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.

Who are HemoGenyx's investors?

HemoGenyx's investors include 43North, ScaleReady, Prevail Partners, Mint Capital.

Where is HemoGenyx headquartered?

HemoGenyx is headquartered in London, United Kingdom.

What does HemoGenyx do?

New treatment for blood diseases, such as leukemia and lymphoma.

What stage is HemoGenyx at?

HemoGenyx is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2026.

MLA

"HemoGenyx — Funding & Investors." VCBacked, April 28, 2026, https://www.vcbacked.co/company/hemogenyx. Accessed July 4, 2026.

APA

VCBacked. (2026). HemoGenyx — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/hemogenyx

Wikipedia (cite web)

{{cite web |title=HemoGenyx — Funding & Investors |url=https://www.vcbacked.co/company/hemogenyx |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2026.